Average Total Weight Loss of 20% With 15% Increase in Lean Body Mass After 8 Months of Combined Therapy NATICK, Mass.--(BUSINESS WIRE)-- Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE ...
Abivax is actively conducting preclinical studies with multiple oral and injectable therapies and will report additional data in Q4 2024. Pre-clinical evaluation of obefazimod combined with etrasimod ...
The new vaccine program will protect against influenza and COVID-19. Pfizer and BioNtech have announced positive topline data from a vaccine phase 1/2 study (NCT0T05596734), demonstrating immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results